6,657
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Antiurolithiatic Property of Moringa oleifera Root Bark

, , , , &
Pages 861-865 | Accepted 17 Dec 2008, Published online: 20 Jan 2009
 

Abstract

In spite of tremendous advances in the field of medicine, there is no truly satisfactory drug for the treatment of renal calculi. In the present study, the efficacy of the root bark of Moringa oleifera Lam. (Moringaceae) as an antiurolithiatic agent was investigated using an experimentally induced urolithiatic rat model. Hyperoxaluria was induced in rats using 0.75% ethylene glycol in water. Aqueous (AqE) (200 mg kg− 1 body weight) and alcoholic extracts (AlcE) (200 mg kg− 1 body weight) of the root bark of M. oleifera were given orally in curative and preventive regimens over a period of 28 days. Both the extracts significantly (P < 0.001) lowered the urinary excretion and kidney retention levels of oxalate, calcium and phosphate. Moreover, elevated serum levels of urea nitrogen, creatinine and uric acid were significantly (P < 0.001) reduced by the extracts. The results were comparable with the standard drug, cystone (750 mg kg− 1 body weight). The reduction of stone forming constituents in urine and their decreased kidney retention reduces the solubility product of crystallizing salts such as calcium oxalate and calcium phosphate, which could contribute to the antiurolithiatic property of root bark of M. oleifera.

Acknowledgements

We express our thanks to Dr. V. Prasad, BSI, Pune for authentication of the plant material. We are grateful to Dr. F.V. Manvi, Principal and Professor A.D. Taranalli, Vice Principal, K.L.E.S's College of Pharmacy, Belgaum, Karnataka, India for providing the facilities necessary to carry out the research work.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.